Evidence map›Paper›PMID 42439800›Full record

ArticleAntimicrobial agents and chemotherapy2026

Antifungal exposure in

Chemsa Le Cœur, Olivier Le Tilly, Adélaïde Chesnay, François Darrouzain, Roger J M Brüggemann, Damien Richard, Fanny Lanternier, Dea Garcia-Hermoso, Adrien Lemaignen, Marion Lacasse

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chemsa Le CœurService de Maladies Infectieuses et Tropicales, Hôpital Bretonneau, CHRU de Tours, Tours, France.ORCID 0009-0009-5401-1307
Olivier Le TillyService de Pharmacologie Médicale, CHRU de Tours, Tours, France.
Adélaïde ChesnayService de Parasitologie-Mycologie-Médecine Tropicale, CHRU de Tours, Tours, France.
François DarrouzainService de Pharmacologie Médicale, CHRU de Tours, Tours, France.
Roger J M BrüggemannDepartment of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, the Netherlands.ORCID 0000-0002-7618-725X
Damien RichardService de Pharmacologie Médicale, CHU Gabriel-Montpied, Clermont-Ferrand, France.
Fanny LanternierService de Maladies Infectieuses et Tropicales, Hôpital Necker, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Dea Garcia-HermosoDépartement de Mycologie, Université Paris Cité, Centre National de Référence des Mycoses invasives et Antifongiques, Institut Pasteur, Paris, France.
Adrien LemaignenService de Maladies Infectieuses et Tropicales, Hôpital Bretonneau, CHRU de Tours, Tours, France.
Marion LacasseService de Maladies Infectieuses et Tropicales, Hôpital Bretonneau, CHRU de Tours, Tours, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diffusionolorofimpenetrationScedosporiumsynovial fluidterbinafinevoriconazole

Identifiers

PMID42439800
PMCPMC13435891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.